位置:首页 > 蛋白库 > KCNKG_HUMAN
KCNKG_HUMAN
ID   KCNKG_HUMAN             Reviewed;         309 AA.
AC   Q96T55; B5TJL9; Q2M2N9; Q5TCF3; Q6X6Z3; Q6X6Z4; Q6X6Z5; Q9H591;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Potassium channel subfamily K member 16;
DE   AltName: Full=2P domain potassium channel Talk-1;
DE   AltName: Full=TWIK-related alkaline pH-activated K(+) channel 1;
DE            Short=TALK-1;
GN   Name=KCNK16; Synonyms=TALK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Pancreas;
RX   PubMed=11263999; DOI=10.1006/bbrc.2001.4562;
RA   Girard C., Duprat F., Terrenoire C., Tinel N., Fosset M., Romey G.,
RA   Lazdunski M., Lesage F.;
RT   "Genomic and functional characteristics of novel human pancreatic 2P domain
RT   K(+) channels.";
RL   Biochem. Biophys. Res. Commun. 282:249-256(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B; C AND D), TISSUE SPECIFICITY,
RP   ALTERNATIVE SPLICING, AND VARIANT HIS-301.
RX   PubMed=12724142; DOI=10.1152/ajpcell.00601.2002;
RA   Han J., Kang D., Kim D.;
RT   "Functional properties of four splice variants of a human pancreatic
RT   tandem-pore K+ channel, TALK-1.";
RL   Am. J. Physiol. 285:C529-C538(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RC   TISSUE=Pancreas;
RX   PubMed=18516069; DOI=10.1038/bjp.2008.213;
RA   Gierten J., Ficker E., Bloehs R., Schlomer K., Kathofer S., Scholz E.,
RA   Zitron E., Kiesecker C., Bauer A., Becker R., Katus H.A., Karle C.A.,
RA   Thomas D.;
RT   "Regulation of two-pore-domain (K2P) potassium leak channels by the
RT   tyrosine kinase inhibitor genistein.";
RL   Br. J. Pharmacol. 154:1680-1690(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-301.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Outward rectifying potassium channel. Produces rapidly
CC       activating and non-inactivating outward rectifier K(+) currents.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- INTERACTION:
CC       Q96T55; P32242: OTX1; NbExp=3; IntAct=EBI-10294109, EBI-740446;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=a;
CC         IsoId=Q96T55-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=Q96T55-3; Sequence=VSP_039865;
CC       Name=c;
CC         IsoId=Q96T55-4; Sequence=VSP_039863;
CC       Name=d;
CC         IsoId=Q96T55-5; Sequence=VSP_039864;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas. Not detectable in the
CC       other tissues tested. {ECO:0000269|PubMed:12724142}.
CC   -!- MISCELLANEOUS: Inhibited by Ba(2+), quinine, quinidine, chloroform and
CC       halothane. Activated at alkaline pH.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF358909; AAK49532.1; -; mRNA.
DR   EMBL; AY253145; AAP82866.1; -; mRNA.
DR   EMBL; AY253146; AAP82867.1; -; mRNA.
DR   EMBL; AY253147; AAP82868.1; -; mRNA.
DR   EMBL; EU978943; ACH86102.1; -; mRNA.
DR   EMBL; AL136087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03982.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03984.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03985.1; -; Genomic_DNA.
DR   EMBL; BC111860; AAI11861.1; -; mRNA.
DR   CCDS; CCDS47420.1; -. [Q96T55-5]
DR   CCDS; CCDS47421.1; -. [Q96T55-4]
DR   CCDS; CCDS47422.1; -. [Q96T55-3]
DR   CCDS; CCDS4843.1; -. [Q96T55-1]
DR   RefSeq; NP_001128577.1; NM_001135105.1. [Q96T55-4]
DR   RefSeq; NP_001128578.1; NM_001135106.1. [Q96T55-3]
DR   RefSeq; NP_001128579.1; NM_001135107.1. [Q96T55-5]
DR   RefSeq; NP_115491.1; NM_032115.3. [Q96T55-1]
DR   RefSeq; XP_016866835.1; XM_017011346.1. [Q96T55-5]
DR   AlphaFoldDB; Q96T55; -.
DR   SMR; Q96T55; -.
DR   BioGRID; 123763; 44.
DR   IntAct; Q96T55; 15.
DR   STRING; 9606.ENSP00000391498; -.
DR   TCDB; 1.A.1.9.10; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q96T55; -.
DR   PhosphoSitePlus; Q96T55; -.
DR   BioMuta; KCNK16; -.
DR   DMDM; 24636281; -.
DR   PaxDb; Q96T55; -.
DR   PRIDE; Q96T55; -.
DR   Antibodypedia; 15706; 41 antibodies from 13 providers.
DR   DNASU; 83795; -.
DR   Ensembl; ENST00000373227.8; ENSP00000362324.4; ENSG00000095981.11. [Q96T55-5]
DR   Ensembl; ENST00000373229.9; ENSP00000362326.5; ENSG00000095981.11. [Q96T55-1]
DR   Ensembl; ENST00000425054.6; ENSP00000391498.2; ENSG00000095981.11. [Q96T55-4]
DR   Ensembl; ENST00000437525.3; ENSP00000415375.2; ENSG00000095981.11. [Q96T55-3]
DR   GeneID; 83795; -.
DR   KEGG; hsa:83795; -.
DR   MANE-Select; ENST00000437525.3; ENSP00000415375.2; NM_001135106.2; NP_001128578.1. [Q96T55-3]
DR   UCSC; uc003ooq.3; human. [Q96T55-1]
DR   CTD; 83795; -.
DR   DisGeNET; 83795; -.
DR   GeneCards; KCNK16; -.
DR   HGNC; HGNC:14464; KCNK16.
DR   HPA; ENSG00000095981; Group enriched (pancreas, stomach).
DR   MIM; 607369; gene.
DR   neXtProt; NX_Q96T55; -.
DR   OpenTargets; ENSG00000095981; -.
DR   PharmGKB; PA30057; -.
DR   VEuPathDB; HostDB:ENSG00000095981; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   GeneTree; ENSGT00940000159813; -.
DR   HOGENOM; CLU_022504_6_0_1; -.
DR   InParanoid; Q96T55; -.
DR   OMA; GEGFYFT; -.
DR   OrthoDB; 897327at2759; -.
DR   PhylomeDB; Q96T55; -.
DR   TreeFam; TF313947; -.
DR   PathwayCommons; Q96T55; -.
DR   Reactome; R-HSA-1299361; TWIK-related alkaline pH activated K+ channel (TALK).
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   SignaLink; Q96T55; -.
DR   BioGRID-ORCS; 83795; 11 hits in 1059 CRISPR screens.
DR   GeneWiki; KCNK16; -.
DR   GenomeRNAi; 83795; -.
DR   Pharos; Q96T55; Tbio.
DR   PRO; PR:Q96T55; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q96T55; protein.
DR   Bgee; ENSG00000095981; Expressed in islet of Langerhans and 32 other tissues.
DR   ExpressionAtlas; Q96T55; baseline and differential.
DR   Genevisible; Q96T55; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; IDA:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IDA:MGI.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003; PTHR11003; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01095; TASKCHANNEL.
PE   1: Evidence at protein level;
KW   Alternative splicing; Ion channel; Ion transport; Membrane; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..309
FT                   /note="Potassium channel subfamily K member 16"
FT                   /id="PRO_0000101767"
FT   TOPO_DOM        1..13
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        14..34
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        98..116
FT                   /note="Pore-forming; Name=Pore-forming 1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        120..140
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        141..165
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        166..186
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        202..221
FT                   /note="Pore-forming; Name=Pore-forming 2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        238..258
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        259..309
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         222..309
FT                   /note="TDPSKHYISVYRSLAAIWILLGLAWLALILPLGPLLLHRCCQLWLLSLRQGC
FT                   GAKAAPGRRPRRGSTAARGVQVTPQDFPISKKGLGS -> HPLNFITPSGLLPSQEPFQ
FT                   TPHGKPESQQIPGSFQKVSSMNVWPLSGMHSPGLAFPLPDCNIPDQERFRPLHPGAWKF
FT                   WPLPLPSSNSKWAPMWLGSSAQV (in isoform c)"
FT                   /evidence="ECO:0000303|PubMed:12724142,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039863"
FT   VAR_SEQ         222..268
FT                   /note="Missing (in isoform d)"
FT                   /evidence="ECO:0000303|PubMed:12724142"
FT                   /id="VSP_039864"
FT   VAR_SEQ         269..309
FT                   /note="LRQGCGAKAAPGRRPRRGSTAARGVQVTPQDFPISKKGLGS -> RGLGVKD
FT                   GAASDPSGLPRPQKIPISA (in isoform b)"
FT                   /evidence="ECO:0000303|PubMed:12724142,
FT                   ECO:0000303|PubMed:18516069"
FT                   /id="VSP_039865"
FT   VARIANT         215
FT                   /note="F -> L (in dbSNP:rs9462527)"
FT                   /id="VAR_063636"
FT   VARIANT         275
FT                   /note="A -> G (in dbSNP:rs1535500)"
FT                   /id="VAR_063637"
FT   VARIANT         301
FT                   /note="P -> H (in dbSNP:rs11756091)"
FT                   /evidence="ECO:0000269|PubMed:12724142, ECO:0000269|Ref.5"
FT                   /id="VAR_052430"
FT   CONFLICT        49
FT                   /note="L -> S (in Ref. 2; AAP82866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        149
FT                   /note="A -> V (in Ref. 2; AAP82867)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="S -> G (in Ref. 2; AAP82866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        205..207
FT                   /note="FAF -> LLS (in Ref. 2; AAP82867)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   309 AA;  34153 MW;  99C4B11EB26B0764 CRC64;
     MPSAGLCSCW GGRVLPLLLA YVCYLLLGAT IFQLLERQAE AQSRDQFQLE KLRFLENYTC
     LDQWAMEQFV QVIMEAWVKG VNPKGNSTNP SNWDFGSSFF FAGTVVTTIG YGNLAPSTEA
     GQVFCVFYAL LGIPLNVIFL NHLGTGLRAH LAAIERWEDR PRRSQVLQVL GLALFLTLGT
     LVILIFPPMV FSHVEGWSFS EGFYFAFITL STIGFGDYVV GTDPSKHYIS VYRSLAAIWI
     LLGLAWLALI LPLGPLLLHR CCQLWLLSLR QGCGAKAAPG RRPRRGSTAA RGVQVTPQDF
     PISKKGLGS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024